Scarica l'app Stockscreener
10.09
0.20%
0.02
Apogee Acquisition Corp Borsa (AACP) Ultime notizie
Apogee Acquisition Restates Q2 2026 Financials, Director and COO Resign - Minichart
Form 4 Apogee Acquisition Corp: APOGEE ACQUISITION SPONSOR LLC (10% Owner) For: 13 October - Investing.com Nigeria
Form 4 Apogee Acquisition Corp: Thomas Lloyd Watson (COO) For: 14 October - Investing.com Nigeria
Q2 errors surface at Apogee Acquisition (AACPR) as its COO and a director resign. - Stock Titan
Financial statements are unchanged as Apogee Acquisition Corp (AACPR) amends share and warrant counts. - Stock Titan
Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026 - Yahoo Finance
Accelevation Launches Roadshow for Proposed IPO of 30 Million Shares - Yahoo Finance
Apogee Enterprises Director Julie K. Streich Receives 2,530 Shares in Award on September 11, 2026 - Kalkine Media
Apogee Enterprises Director Julie K. Streich Acquires 2,530 Shares at No Cost - Kalkine Media
abrdn Income Credit Strategies Fund cuts monthl... - Pluang
abrdn Income Credit Strategies Fund (ACP) Announces Change to Monthly Distribution Expected to Be Maintained for at Least the Next 12 Months - TradingView
abrdn Income Credit Strategies Fund cuts monthly distribution to $0.055 per share from $0.0775 - Bitget
Aperture AC to Take Atlantic HPC Public in $150 Million Deal - Yahoo Finance
Apogee Therapeutics (NASDAQ: APGE) leaves Nasdaq in AbbVie cash buyout - Stock Titan
Shareholders will receive $0.328125 per share on Sept. 30 - Stock Titan
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Eastern Progress
AbbVie-owned Apogee Therapeutics (APGE) pulls unsold stock - Stock Titan
Apogee Therapeutics (APGE) director-linked funds fully exit in AbbVie deal - stocktitan.net
Apogee Therapeutics (APGE) CMO cashes out stock and options in AbbVie deal - Stock Titan
Director cashes out Apogee (NASDAQ: APGE) stake in AbbVie merger - Stock Titan
Apogee merger pays $135.11 per share in cash | APGE SEC FilingForm SCHEDULE 13D/A - stocktitan.net
AbbVie Finalizes $10.9 Billion Acquisition of Apogee Therapeutics, Initiates Nasdaq Delisting - Kalkine Media
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline - Dermatology Times
ACP/PA Stock Price and Chart — NYSE:ACP/PA - TradingView
AbbVie Completes Acquisition of Apogee Therapeutics - Investing News Network
AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics - minichart.com.sg
AbbVie Completes $10.9 Billion Apogee Acquisition, Reaffirms 2026 EPS Guidance - Minichart
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio - TipRanks
AbbVie seals $11B acquisition of Apogee Therapeutics (ABBV:NYSE) - Seeking Alpha
AbbVie Completes Acquisition of Apogee Therapeutics - finance.yahoo.com
Apogee Therapeutics (APGE) CEO’s stock and options paid out in AbbVie deal - Stock Titan
AbbVie’s $10.9 billion deal adds a late-stage eczema treatment - Stock Titan
TOMI Regains Nasdaq Equity Compliance After $2.5M Debt Conversion - minichart.com.sg
ACP Edges Lower by 0.59%: abrdn Income Credit Strategies Fund Holds Above Key SupportRounding Top - dars.gov.et
abrdn Income Credit Strategies Fund (ACP) Ticks Up 1.39% as Shares Hold Above Key SupportIndex Put Call - vinanet.vn
ARISTEIA CAPITAL, L.L.C. Initiates Position in Apogee Acquisitio - GuruFocus
ABBV climbs around 1.5% after double-digit revenue growth and Apogee acquisition - Traders Union
Apogee Acquisition Corp Q2 2026: Net income $1.13M, EPS $0.08— 10-Q Summary - TradingView
Apogee Acquisition (AACP) faces 2027 deal-or-liquidation deadline - Stock Titan
Apogee Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Abrdn Income Credit Strategies Fund flagged as sell due to unsustainable yields and NAV erosion risks. - Pluang
ACP: NAV Erosion Will Continue (NYSE:ACP) - Seeking Alpha
AbbVie Raises $10 Billion in Debt to Fund Apogee Acquisition - Minichart
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com UK
AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan
AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey
Osprey Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 21, 2026 - Yahoo Finance
Apogee Acquisition Corp SEC Filing (Aug 14, 2026) - Stock Titan
0.00%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):